CELATOR PHARMACEUTICALS INC. COMMON STOCK
CPXX
CPXX was delisted on the 11th of July, 2016.
11 hedge funds and large institutions have $10M invested in CELATOR PHARMACEUTICALS INC. COMMON STOCK in 2014 Q2 according to their latest regulatory filings, with 5 funds opening new positions, 2 increasing their positions, 2 reducing their positions, and 1 closing their positions.
400% more first-time investments, than exits
New positions opened: 5 | Existing positions closed: 1
57% more funds holding
Funds holding: 7 → 11 (+4)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
0% more repeat investments, than reductions
Existing positions increased: 2 | Existing positions reduced: 2
8% less capital invested
Capital invested by funds: $10.8M → $10M (-$823K)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
California Public Employees Retirement System
Sacramento,
California
|
+$242K |
| 2 |
Bank of America
Charlotte,
North Carolina
|
+$134K |
| 3 |
Vanguard Group
Malvern,
Pennsylvania
|
+$94.7K |
| 4 |
ACI
Alpha Cubed Investments
Irvine,
California
|
+$88.4K |
| 5 |
HLA
Hamilton Lane Advisors
Conshohocken,
Pennsylvania
|
+$47.6K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SM
Sabby Management
Miami Beach,
Florida
|
-$783K |
| 2 |
U
UBS
Zurich,
Switzerland
|
-$10K |
| 3 |
CPA
Cowen Prime Advisors
New York
|
-$2.07K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
CC
1
Caxton Corporation
Princeton,
New Jersey
| $6.65M | – | – | – |
|
|
OM
2
Opaleye Management
Boston,
Massachusetts
| $1.07M | +$36.9K | +13,402 | +4% |
|
|
SM
3
Sabby Management
Miami Beach,
Florida
| $1.01M | -$783K | -284,453 | -45% |
|
|
4
Vanguard Group
Malvern,
Pennsylvania
| $664K | +$94.7K | +34,400 | +18% |
|
|
5
California Public Employees Retirement System
Sacramento,
California
| $260K | +$242K | +87,900 | New |
|
|
6
Bank of America
Charlotte,
North Carolina
| $144K | +$134K | +48,696 | New |
|
|
ACI
7
Alpha Cubed Investments
Irvine,
California
| $95K | +$88.4K | +32,092 | New |
|
|
HLA
8
Hamilton Lane Advisors
Conshohocken,
Pennsylvania
| $51K | +$47.6K | +17,280 | New |
|
|
CPA
9
Cowen Prime Advisors
New York
| $36K | -$2.07K | -750 | -6% |
|
|
SIM
10
Spark Investment Management
New York
| $31K | +$28.9K | +10,500 | New |
|
|
U
11
UBS
Zurich,
Switzerland
| – | -$10K | -3,045 | Closed |
|
CPXX Hedge Fund Activity: Q2 2014 in Review
11 of the 3,481 institutional investors tracked by Wall St. Rank reported a position in CELATOR PHARMACEUTICALS INC. COMMON STOCK (CPXX) for Q2 2014, worth a combined $10M — down 7.6% from $10.8M a quarter earlier.
Buyers outnumbered sellers: 5 funds opened new CPXX positions and 1 closed out — a net gain of 4 holders — while 2 added to existing stakes and 2 trimmed.
The largest buyer was California Public Employees Retirement System, opening a new position worth an estimated $242K. The largest seller was Sabby Management, cutting an estimated $783K.
- 11 institutional investors held CELATOR PHARMACEUTICALS INC. COMMON STOCK (CPXX) as of Q2 2014, up from 7 in Q1 2014.
- Funds reported $10M of CELATOR PHARMACEUTICALS INC. COMMON STOCK stock for Q2 2014, down 7.6% quarter-over-quarter.
- 5 funds opened new CELATOR PHARMACEUTICALS INC. COMMON STOCK positions in Q2 2014 and 1 closed out, a net change of +4 holders.
- The largest CELATOR PHARMACEUTICALS INC. COMMON STOCK buyer in Q2 2014 was California Public Employees Retirement System, an estimated $242K added.
- The largest CELATOR PHARMACEUTICALS INC. COMMON STOCK seller in Q2 2014 was Sabby Management, an estimated $783K sold.
Based on aggregated 13F filings for Q2 2014.